ABVX compared with AURA: revenue, margins and what each company keeps, and the suppliers and customers both name

ABVXAbivax S.A.

Mkt capRevenueRevenue

AURAAura Biosciences, Inc.

Mkt capRevenueRevenue

Compare

ABVXAbivax S.A.

AURAAura Biosciences, Inc.

Price

Mkt cap

Revenue

Revenue flow

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

ABVXAbivax S.A.

84.73▼−2.15%· post 84.72

Mkt cap$6.0B

AURAAura Biosciences, Inc.

6.03▼−1.87%· post 6.03

ClosedNov 2 '26

Mkt cap$636.7M

Compare

ClosedNov 2 '26

ABVXAbivax S.A.

AURAAura Biosciences, Inc.

84.73▼−2.15%post 84.72

Price

6.03▼−1.87%post 6.03

$6.0B

Mkt cap

$636.7M

ABVX84.73▼−2.15%vsAURA6.03▼−1.87%ClosedNov 2 '26

ABVX: latest quarter not drawable. AURA: latest quarter not drawable.Method ›

direct ties · both sidesSources ›

direct ties · both sides

No disclosed counterparties: ABVX, AURA.

Role chip = supplier or customerSource: SEC EDGAR

rebased to 0%

ABVX, solidAURA, dashed